Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Theravance Inc. (THRX)

-NasdaqGS
26.47 Down 0.66(2.43%) 4:00PM EDT
|After Hours : 26.40 Down 0.07 (0.26%) 4:00PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 1,648   439   1,327   1,344  
Cost of Revenue -   -   -   -  
Gross Profit 1,648   439   1,327   1,344  
Operating Expenses
Research Development33,631  33,395  31,739  26,416  
Selling General and Administrative16,469  12,282  11,374  8,315  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (48,452) (45,238) (41,786) (33,387)
Income from Continuing Operations
Total Other Income/Expenses Net209  156  8,382  (1,237)
Earnings Before Interest And Taxes(48,243)(45,082)(33,404)(34,624)
Interest Expense1,686  1,901  3,025  2,736  
Income Before Tax(49,929)(46,983)(36,429)(37,360)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(49,929)(46,983)(36,429)(37,360)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (49,929) (46,983) (36,429) (37,360)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (49,929) (46,983) (36,429) (37,360)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.